Ticker
AVTXCompany Name
AVALO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cost of Revenue |
---|---|
6/30/2025 | $ -627K |
3/31/2025 | $ -284K |
12/31/2024 | $ -366K |
9/30/2024 | $ -672K |
6/30/2024 | $ 289K |
3/31/2024 | $ 654K |
12/31/2023 | $ 1.28M |
9/30/2023 | $ 2.13M |
6/30/2023 | $ 2.41M |
3/31/2023 | $ 3.27M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Minimum
Sep 30, 2020
Maximum
Jun 30, 2022
Average
Median
filtered constituents | 2.94K |
---|---|
min | $ -168.96M |
max | $ 758.54M |
average | $ 111.94M |
median | $ 13.43M |
std | $ 181.77M |